Stock Price
264.50
Daily Change
-3.30 -1.23%
Monthly
4.59%
Yearly
64.44%
Q2 Forecast
257.81

UCB reported EUR49M in Interest Expense on Debt for its fiscal semester ending in December of 2025.





Interest Expense On Debt Change Date
Alcon AG USD 54M 3M Dec/2025
Amarin USD 3K 5K Dec/2024
argenx SE USD 828K 165K Dec/2025
AstraZeneca USD 484M 181M Dec/2025
Bayer EUR 675M 87M Dec/2025
Galapagos EUR 1.72M 940K Sep/2025
Genmab DKK 10M 27M Dec/2025
GlaxoSmithKline GBP 188M 21M Dec/2025
GRIFOLS EUR 141.43M 61.28M Jun/2025
Hikma Pharmaceutical USD 67M 47M Dec/2025
Lonza CHF 84M 14M Jun/2025
Merck EUR 121M 5M Dec/2025
Novartis USD 304M 23M Dec/2025
Orion EUR 600K 600K Sep/2025
Recordati EUR 22.13M 1.43M Dec/2025
Roche Holding CHF 304M 7.5M Jun/2025
Sanofi EUR -25M 252M Dec/2025
UCB EUR 49M 29M Dec/2025
Unibail Rodamco EUR 273.25M 65.05M Jun/2024